Dark Blue Therapeutics Ltd
Dark Blue Therapeutics is an innovative cancer drug discovery company focused on developing precision oncology medicines by exploiting cancer vulnerabilities and dependencies. They leverage insights from academia and a robust medicinal chemistry platform to create transformative therapies for patients with high unmet needs.
Founded: 4 Jun 2020
Industries:
72110 - Research and experimental development on biotechnology
Website: darkbluetx.com
Phone: +441865803112
Location: Oxford
Products & Services
• biotechnology company
• cancer drug discovery
• cancer therapies
• drug discovery
• first-in-class cancer therapies
• oncology
• precision medicine
• precision oncology medicines
• single agent medicines
Financial Snapshot
Cash in Bank
Turnover
EBITDA
Gross Profit
Total Liabilities
Employees
Unlock financial data with Pro Start Free Trial →
People
Officers
5
Shareholders
29
Controllers (PSC)
5
Alastair Graham Mackinnon
Director • British • Lives in England • Born in Nov 1970
Thomas Hanke
Director • German • Lives in Germany • Born in Nov 1964
James Carmichael
Director • British • Lives in United Kingdom • Born in Dec 1950
Justian Craig Fox
Director • British • Lives in England • Born in Nov 1975
Edwin Moses
Director • British,belgian • Lives in Belgium • Born in Oct 1954
Registered Office Address
Hayakawa Building, Edmund Halley Road
The Oxford Science Park
Oxford
OX4 4GB
United Kingdom
Basic Information
LTD
4 Jun 2020
ENGLAND WALES
Yes
Industry Classification
72110
Company Attributes
N/A
N/A
N/A
N/A
Summary
12
Officers
5
PSCs
0
Filings